Picture of Swedish Orphan Biovitrum AB (publ) logo

SOBI — Swedish Orphan Biovitrum AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Sobi Raises 2024 Revenue Growth Outlook

July 16 (Reuters) - Swedish Orphan Biovitrum AB (publ)
 SOBIV.ST :
    * OUTLOOK 2024: REVENUE IS ANTICIPATED TO GROW BY LOW
DOUBLE-DIGIT
PERCENTAGE AT CER (PREVIOUSLY HIGH SINGLE-DIGIT)
    * OUTLOOK 2024: ADJUSTED EBITA MARGIN IS ANTICIPATED TO BE
IN
MID-30S PERCENTAGE OF REVENUE (UNCHANGED)
    * Q2 EBITA WAS SEK 1,486 M (1,009), CORRESPONDING TO A
MARGIN OF
27 PER CENT (21)

Source text for Eikon:  ID:nWkr8gDCRk 
Further company coverage:  SOBIV.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Swedish Orphan Biovitrum AB (publ)

See all news